Sector ratings ANGLE plc

Equities

Delayed London S.E. Other stock markets 14:45:53 13/09/2024 BST			5-day change	1st Jan Change
11.30 ^GBX	+0.44%		-7.50%	-5.53%

08-23	Angle hails publication of research data in science journal	AN
08-22	Angle plc Announces the Publication of One of the Company's Clinical Studies That Was Submitted to the FDA for De Novo Regulatory Clearance of the Parsortix PC1 System	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	Composite Visibility	ESG Refinitiv	Capi. ($)
ANGLE PLC	-		-	47.44M
SARTORIUS AG			A	16.67B
QUIDELORTHO CORPORATION			C+	3.01B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-		-	1.38B
BIOTAGE AB			B+	1.42B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.			-	1.27B
REVENIO GROUP OYJ			-	1.01B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.			-	783M
CELLAVISION AB			C+	631M
VAREX IMAGING CORPORATION	-		B+	469M
BODITECH MED INC.			-	298M
908 DEVICES INC.	-		D+	120M
SENSUS HEALTHCARE, INC.	-		-	95.88M
HUVITZ CO., LTD.		-	-	81.62M
Average			B-	1.95B
Weighted average by Cap.			B-